RESEARCH-USE BIOSIMILAR ANTIBODY
Semorinemab
Monoclonal antibody · IgG4
Semorinemab (RG 6100) is an anti-Tau humanized IgG4 monoclonal antibody, targets the N-terminal portion of the Tau protein (amino acid residues 6-23). Semorinemab binds with human Tau with a Kd value of 3.8 nM. Semorinemab can be used for the research of Alzheimer's Disease.
TARGETMAPT
YMonoclonal antibody
CATALOGSC-BS-191
CATALOG NUMBERSC-BS-191
MOLECULAR WEIGHTApprox. 145.1 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Semorinemab (RG 6100) is an anti-Tau humanized IgG4 monoclonal antibody, targets the N-terminal portion of the Tau protein (amino acid residues 6-23). Semorinemab binds with human Tau with a Kd value of 3.8 nM. Semorinemab can be used for the research of Alzheimer's Disease.
Semorinemab is a recombinant research-use antibody directed against MAPT.